Posted in | News | Business | Packaging

Cenveo Acquires Envelope Products Business of MeadWestvaco

Cenveo, Inc. (NYSE: CVO) announced today that it completed its previously announced acquisition of the Envelope Products Group of MeadWestvaco (NYSE: MWV).

The Envelope Products Group manufactures and distributes envelope products for the billing, financial and direct mail markets and has approximately 900 employees. The combined companies will form the largest, most innovative envelope company in the world.

Robert G. Burton, Sr., Chairman and Chief Executive Officer stated:

"Today marks an important milestone in achieving our goal of significantly enhancing and solidifying our industry leading envelope platform.  This acquisition brings together two industry leaders, both of which have much to offer one another and creates a platform that will truly be the envy of the industry. We are impressed by the degree of synergy that is available and are working to ensure that we combine the best of both organizations. I want to personally welcome the employees of the Envelope Products Group to the Cenveo family.  The acquisition is expected to be accretive to earnings in 2011 and will be deleveraging to our balance sheet."

Cenveo (NYSE: CVO), headquartered in Stamford, Connecticut, is a leader in the management and distribution of print and related products and solutions.  The Company provides its customers with low-cost alternatives within its core businesses of labels and forms manufacturing, packaging and publisher offerings, envelope production, and printing; supplying one-stop solutions from design through fulfillment. Cenveo delivers everyday for its customers through a network of production, fulfillment, content management, and distribution facilities across the globe.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.